EC
DCPH

EcoR1 Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

EcoR1 Capital’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-993,000
Closed -$12.6M – 61
2023
Q3 		$12.6M Buy
+993,000
New +$13.7M 0.43% 34
2017
Q4 		– Sell
-45,000
Closed -$855K – 46
2017
Q3 		$855K Buy
+45,000
New +$824K 0.11% 38

Other funds holding DCPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EcoR1 Capital's DCPH Position: Q4 2023 in Review

EcoR1 Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2023, closing a stake of 993,000 shares — an estimated $12.6M sold.

EcoR1 Capital first reported a position in DCPH in Q3 2017 and held it in 2 quarters. The position peaked at $12.6M in Q3 2023. 164 funds tracked by Wall St. Rank hold DCPH as of Q4 2023.

  • EcoR1 Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • EcoR1 Capital sold 993,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $12.6M.
  • EcoR1 Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • EcoR1 Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $12.6M in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on EcoR1 Capital's 13F filing for Q4 2023, filed 14 Feb 2024.